# NOGO-A in Multiple Sclerosis FTIH

> **NCT01424423** · PHASE1 · TERMINATED · sponsor: **GlaxoSmithKline** · enrollment: 3 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Placebo
- **DRUG:** GSK1223249

## Key facts

- **NCT ID:** NCT01424423
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-02-11
- **Primary completion:** 2010-08-26
- **Final completion:** 2010-08-26
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2017-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01424423

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01424423, "NOGO-A in Multiple Sclerosis FTIH". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01424423. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*